Whitepaper

How to Win the Biosimilars Race in the European Union Onco-Therapeutics Market in 2020?

Market Research

The healthcare market has been growing for biosimilars in the European Union (EU), however, the rosy picture is expected to change as the long term sustainability of the pharmaceutical market is expected to come under lens due to shortage of big biologic patent expiries.

The entry of Chinese and Singaporean drug manufacturers causes a slight change of focus to the Russian and Central Europe region and also because of a growing number of new innovative drugs targeted at focused patient groups. 

Download this Whitepaper, based on a study conducted by SG Analytics to know more.

To know more...




Authors

Related Topics

ATxSG Broadcast Asia 2024

Whitepapers

ATxSG BroadcastAsia 2024: Key Trends

ATxSG is one of the leading technology conferences in Asia-Pacific with two primary focus avenues, i.e., BroadcastAsia and CommunicAsia, with close to...

NAB 2024 Key Trends

Whitepapers

NAB 2024 Key Trends

SG Analytics (SGA)’s media and broadcast research & consulting team surveyed 13 vendors attending the 2024 NAB Show in Las Vegas in April 2024....

Whitepaper - ESG-M&E - Sustainable Media

Whitepapers

A Shift toward Sustainable Media Consumption Imminent

Short description & Key Takeaways for the website: There are roughly 500+ OTT TV & video services globally with 6.3bn users worldwide generating...

We bring comprehensive data driven insights to everyone, everywhere